D. Amadori
Impact in
- Oncology top 1%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Cancer Research top 2%
- Breast Cancer Treatment Studies
Papers in
- Oncology 109
- Cancer Treatment and Pharmacology 55
- HER2/EGFR in Cancer Research 28
- Colorectal Cancer Treatments and Studies 13
- Cancer Cells and Metastasis 11
-
- Breast Cancer Treatment Studies 34
- Co-authors
- Oriana NanniMarco MaltoniWainer ZoliEmanuela ScarpiGiovanni Luca FrassinetiAntonio RussoLuca RicottiGuglielmina Nadia Ranzani
- Journals
- Journal of Clinical Oncology (27 papers)Annals of Oncology (22 papers)European Journal of Cancer (10 papers)Cancer Research (10 papers)British Journal of Cancer (8 papers)
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
D. Amadori
166 papers receiving 3.8k citations
Peers
Comparison fields: 5 of 134
- Oncology 1.8k
- Cancer Research 915
- Pulmonary and Respiratory Medicine 1.1k
- Pathology and Forensic Medicine 518
- Gastroenterology 127
Countries citing papers authored by D. Amadori
This map shows the geographic impact of D. Amadori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Amadori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Amadori more than expected).
Fields of papers citing papers by D. Amadori
This network shows the impact of papers produced by D. Amadori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Amadori. The network helps show where D. Amadori may publish in the future.
Co-authors
The 25 scholars most cited alongside D. Amadori, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 7 | |
| 2 | 2017 | 5 | |
| 3 | 2015 | 98 | |
| 4 | Tolerability of sunitinib in combination with docetaxel and trastuzumab as first-line therapy for HER2+advanced breast cancer : Abstract #4120 | 2009 | 1 |
| 5 | 2009 | 140 | |
| 6 | 2006 | 158 | |
| 7 | 2006 | 9 | |
| 8 | 2003 | 5 | |
| 9 | 2001 | 19 | |
| 10 | 2001 | 59 | |
| 11 | 2000 | 14 | |
| 12 | 1999 | 55 | |
| 13 | 1998 | 12 | |
| 14 | Prospective use of tumor proliferative activity for adjuvant therapy in node-negative breast cancer patients | 1997 | 1 |
| 15 | A phase I/II study of sequential doxorubicin and paclitaxel in the treatment of advanced breast cancer. | 1996 | 35 |
| 16 | 1996 | 111 | |
| 17 | 1994 | 5 | |
| 18 | 1993 | 30 | |
| 19 | 1991 | 2 | |
| 20 | 1990 | 54 |
About D. Amadori
D. Amadori is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Genetics, having authored 173 papers that have together received 3.9k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (55 papers), Breast Cancer Treatment Studies (34 papers), HER2/EGFR in Cancer Research (28 papers), Advanced Breast Cancer Therapies (22 papers), Colorectal Cancer Treatments and Studies (13 papers), Gastric Cancer Management and Outcomes (12 papers), Helicobacter pylori-related gastroenterology studies (11 papers) and Cancer Cells and Metastasis (11 papers). The work is most often cited by research in Oncology (1.8k citations), Cancer Research (915 citations), Pulmonary and Respiratory Medicine (1.1k citations), Pathology and Forensic Medicine (518 citations) and Gastroenterology (127 citations). D. Amadori has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Oriana Nanni, Marco Maltoni, Wainer Zoli, Emanuela Scarpi, Giovanni Luca Frassineti, Antonio Russo, Luca Ricotti, Guglielmina Nadia Ranzani, Attilio Giacosa and Adriano Decarli. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, Cancer Research and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.